Skip to main content
OpenTrials

Clinical trial condition

Macular Degeneration

Explore clinical trials studying Macular Degeneration. Study availability and eligibility vary by location and protocol.

399 public trials 47 recruiting studies
Refine in advanced search Browse all conditions

Macular Degeneration trial results

Recruiting

A Phase 3 Study to Evaluate the Efficacy and Safety of Intravitreal KSI-101 in Participants With Macular Edema Secondary to Inflammation (MESI) - PEAK

NCT06990399

Conditions
Eye Diseases, Macular Degeneration, Macular Edema, +3 more
Locations
  • AZ Retina & Vitreous Consultants Phoenix, Arizona, United States
  • Research Network Arizona Scottsdale, Arizona, United States
  • California Retina Consultants (Bakersfield) Bakersfield, California, United States
  • Global Research Management, Inc. Glendale, California, United States
View all 56 locations
View Trial Details
Recruiting

A Phase 3 Study to Evaluate the Efficacy and Safety of Intravitreal KSI-101 in Participants With Macular Edema Secondary to Inflammation (MESI) - PINNACLE

NCT06996080

Conditions
Eye Diseases, Macular Degeneration, Macular Edema, +3 more
Locations
  • AZ Retina & Vitreous Consultants Phoenix, Arizona, United States
  • Research Network Arizona Scottsdale, Arizona, United States
  • California Retina Consultants (Bakersfield) Bakersfield, California, United States
  • Global Research Management, Inc. Glendale, California, United States
View all 56 locations
View Trial Details
Recruiting

Phase 1/2 Open-Label Dose-Escalation Study to Evaluate Safety of a Single Intravitreal Injection of RTx-021 in Patients With Stargardt Disease

NCT07439887

Conditions
Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Eye Diseases, Eye Diseases, Hereditary, +5 more
Locations
  • RayTx Clinical Site Bakersfield, California, United States
  • UPMC Vision Institute Pittsburgh, Pennsylvania, United States
  • RayTx Clinical Site Bellaire, Texas, United States
View Trial Details
Recruiting

Prescreening Study to Identify Potential Stargardt Participants for ACDN-01 Clinical Trials (STARPATH)

NCT06445322

Conditions
Cone Rod Dystrophy, Cone-Rod Dystrophies, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, +10 more
Locations
  • University of San Francisco San Francisco, California, United States
  • Vitreo Retinal Associates Gainesville, Florida, United States
  • Wilmer Eye Institute at John Hopkins Baltimore, Maryland, United States
  • Massachusetts Eye and Ear Boston, Massachusetts, United States
View Trial Details
Recruiting

Study to Evaluate ACDN-01 in ABCA4-related Stargardt Retinopathy (STELLAR)

NCT06467344

Conditions
Cone Rod Dystrophy, Cone-Rod Dystrophies, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, +10 more
Locations
  • University of San Francisco San Francisco, California, United States
  • Vitreo Retinal Associates Gainesville, Florida, United States
  • Bascom Palmer Eye Institute Miami, Florida, United States
  • Wilmer Eye Institute at John Hopkins Baltimore, Maryland, United States
View Trial Details

Related conditions